Cancer cells undergo transient EMT and MET phenomena or vice versa, along with the parallel interplay of various markers, often correlated as the determining factor in decoding metabolic profiling of breast cancers. Moreover, various cancer signaling pathways and metabolic changes occurring in breast cancer cells modulate the expression of such markers to varying extents. The existing research completed so far considers the expression of such markers as determinants regulating the invasiveness and survival of breast cancer cells. Therefore, this manuscript is cross-talk among the expression levels of such markers and their correlation in regulating the aggressiveness and invasiveness of breast cancer. We also attempted to cover the possible EMT-based metabolic targets to retard migration and invasion of breast cancer.
CITATION STYLE
Pal, A. K., Sharma, P., Zia, A., Siwan, D., Nandave, D., Nandave, M., & Gautam, R. K. (2022, June 1). Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective. Pathophysiology. MDPI. https://doi.org/10.3390/pathophysiology29020017
Mendeley helps you to discover research relevant for your work.